The Patent Finder

Terms ending in 2038

CureVac AG

Every in-force patent on CureVac AG's record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,371,699Nucleic Acids Encoding CRISPR-Associated Proteins and Uses Thereof
In force
 · High confidence
CureVac SEIn forceHigh confidence
US 12,533,422Modified RNA with Decreased Immunostimulatory Properties
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,602,557Bunyavirales Vaccine
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,397,048Bunyavirales Vaccine
In force
 · Medium confidence
CureVac SEIn forceMedium confidence
US 12,649,914Method of RNA in Vitro Transcription Using a Buffer Containing a Dicarboxylic Acid or Tricarboxylic Acid or a Salt Thereof
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,542,490RNAs for Wound Healing
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,524,066Henipavirus Vaccine
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 11,692,002RNA Sequence Adaptation
In force
 · High confidence
Curevac SEIn forceHigh confidence
US 12,569,549Flavivirus Vaccine
In force
 · High confidence
Sanofi R&D VaccinsIn forceHigh confidence
US 11,525,158Linear Double Stranded DNA Coupled to a Single Support or a Tag and Methods for Producing Said Linear Double Stranded DNA
In force
 · High confidence
Curevac SEIn forceHigh confidence
2 more term ends in 2038 · Pro
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Upgrade to Pro
11 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited